VCID: 17604872
Profile

Corporate information

Investment activity status
Active investor

Selected investments

Country Date Notes
Blend Therapeutics Inc
Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. 		United States 7 Jan 2015 Series B
Initial investment. Round participant. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.